Susceptibilities of MDR Mycobacterium tuberculosis isolates to unconventional drugs compared with their reported pharmacokinetic/pharmacodynamic parameters-Reference-Cited by-同舟云学术

Susceptibilities of MDR Mycobacterium tuberculosis isolates to unconventional drugs compared with their reported pharmacokinetic/pharmacodynamic parameters

Published:2017-02-20 Issue:6 Volume:72 Page:1678-1687
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Cavanaugh Joseph S.¹,Jou Ruwen²,Wu Mei-Hua²,Dalton Tracy¹,Kurbatova Ekaterina¹,Ershova Julia¹,Cegielski J. Peter¹,

Affiliation:

1. United States Centers for Disease Control and Prevention, Atlanta, GA, USA

2. Taiwan Centers for Disease Control, Taipei, Taiwan, Republic of China

Funder

NIH

US Agency for International Development and the US Centers for Disease Control and Prevention

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/72/6/1678/24332007/dkx022.pdf

Reference77 articles.

1. Repurposing—a ray of hope in tackling extensively drug resistance in tuberculosis;Maitra;Int J Infect Dis,2015

2. Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study;Dalton;Lancet,2012

3. Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis;Palomino;Antimicrob Agents Chemother,2002

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposing of anti-malarial drugs for the treatment of tuberculosis: realistic strategy or fanciful dead end?;Malaria Journal;2024-05-03

2. Molecular mechanisms of resistance and treatment efficacy of clofazimine and bedaquiline against Mycobacterium tuberculosis;Frontiers in Medicine;2024-01-10

3. Clofazimine nanoclusters show high efficacy in experimental TB with amelioration in paradoxical lung inflammation;Biomaterials Advances;2023-11

4. The In vitro activity of carbapenems alone and in combination with β-lactamase inhibitors against difficult-to-treat mycobacteria; Mycobacterium tuberculosis, Mycobacterium abscessus, and Mycobacterium avium complex: A systematic review;INT J MYCOBACT;2023

5. Tools to Alleviate the Drug Resistance in Mycobacterium tuberculosis;Molecules;2022-10-17